Northwest Biotherapeutics reported $31.8M in Loan Capital for its fiscal quarter ending in September of 2025.





Loan Capital Change Date
Agenus USD 169.66M 146.06M Dec/2025
AstraZeneca USD 26.14B 19.58B Dec/2025
Bristol-Myers Squibb USD 42.85B 1.62B Dec/2025
Eisai JPY 134.77B 12M Dec/2025
Infinity Pharmaceuticals USD 0 0 Jun/2022
Merck USD 39.97B 6B Sep/2025
Northwest Biotherapeutics USD 31.8M 11.49M Sep/2025
Pfizer USD 57.41B 93M Sep/2025
Plus Therapeutics USD 3.79M 322K Dec/2022
Roche Holding CHF 27.43B 966M Dec/2025